CA-PONY.AI
7.3.2024 08:55:29 CET | Business Wire | Press release
Pony.ai, a leading global autonomous mobility company, held a Memorandum of Understanding (MoU) signing ceremony today with the Government of the Grand Duchy of Luxembourg (“The Government”) to advance the development of autonomous mobility in Luxembourg. The MoU was signed by Pony.ai Co-Founder and CEO Dr. James Peng and Luxembourg’s Minister of the Economy Lex Delles. This MoU represents a collaborative partnership between Luxembourg and Pony.ai, with the objective of fostering the research, development, and deployment of autonomous vehicles in Luxembourg.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240306928526/en/
Delegation from the Government of the Grand Duchy of Luxembourg visits Pony.ai’s office in Fremont, California, March 6, 2024 (Photo: Business Wire)
As a global leader in innovation and technology, Luxembourg presents an excellent opportunity for Pony.ai to further develop its leading autonomous mobility technology in Europe. Pony.ai, with the support of Luxinnovation and local stakeholders, intends to set up a regional hub in Luxembourg, which will serve as a center for Pony.ai’s cutting-edge research and development of autonomous vehicle technology. Pony.ai’s Luxembourg-based hub will be pivotal in driving technological advancements and tailoring solutions for the European market. In addition, the Government and Pony.ai aim to develop a robust local network to support operational capabilities in Luxembourg. Pony.ai looks forward to building strong local partnerships to support this effort.
Pony.ai co-founder and CEO Dr. James Peng said: “As a leading global autonomous vehicle company, Pony.ai is delighted to partner with Luxembourg as we continue our global expansion. We aim to bring to this partnership our cutting-edge AV technology, comprehensive training programs, and a commitment to establish a regional hub in Luxembourg as we continue our global expansion.”
Luxembourg Minister of the Economy Lex Delles said: “The intelligent mobility sector is one of our priorities with regard to the diversification of Luxembourg’s economy. Our aim is to make the Grand Duchy a pioneer in the field of autonomous driving on a European scale. As such, I am very pleased with the signature of an MoU with Pony.ai, a leader in autonomous mobility technologies and services. The signature today formalizes our collaboration and is an important step towards creating a synergy between the technical expertise of Pony.ai and the Luxembourg government's political strategy. The latter aims to promote research and technological development, job creation and sustainable economic growth.”
Pony.ai is a leader in autonomous mobility and in the commercialization of autonomous driving, operating Robotaxi, Robotruck and Personally Owned Vehicle (POV) business units, developing the safest autonomous driving capabilities on a global scale. Pony.ai is excited to continue its expansion into Luxembourg and the European market. For the past year, Pony.ai has engaged in detailed conversations surrounding robotaxi deployment use cases and opportunities with local stakeholders in Luxembourg and believes the country is an exciting and innovative region to introduce Pony.ai’s leading autonomous vehicles.
About Pony.ai
Leading global autonomous driving company Pony.ai, Inc. (“Pony.ai”) is pursuing an ambitious vision for autonomous mobility. We aim to bring safe, sustainable, and accessible mobility to the entire world. We believe that autonomous technology can make our roads exponentially safer for travelers. Founded in late 2016, Pony.ai has been a pioneer in extending autonomous mobility technologies and services at a rapidly expanding footprint of sites around the world. Pony.ai has formed partnerships with leading OEMs, including Toyota, SAIC, SANY, FAW Group, GAC Group, etc. To date, Pony.ai has driven over 30 million autonomous testing and operation kilometers (over 18.6 million miles) on open roads worldwide.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306928526/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mexico Becomes the First Market Worldwide to Receive Approval for Galderma’s Restylane® Shaype™ for Both Chin and Its First Jawline Indication13.11.2026 07:00:00 CET | Press release
Restylane Shaype is now approved in Mexico for temporary augmentation in the chin area and improvement of jawline definition,1 with launch anticipated in H1 2027 Already approved across various markets globally for the chin area,2 this marks Restylane Shaype’s first approval for the jawline worldwide1 The first-and-only shaper on the hyaluronic acid (HA) market, Restylane Shaype features the firmest HA gel available and is powered by proprietary NASHA HD™ technology, developed to build and shape on bone for instant, natural-looking contour and definition3-6 The approval reinforces Galderma's commitment to advancing innovation in the HA category, enabling the company to meet diverse patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that Restylane Shaype has been approved for temporary augmentation in the chin area and improvement of jawline definition in Mexico.1 This is the product’s first approval globally for the jawline, and further expan
vVARDIS Announces Pricing of Initial Public Offering13.11.2026 06:02:00 CET | Press release
vVARDIS Holding AG (“vVARDIS”), a Swiss healthcare company operating in the dental med-tech sector, today announced the pricing of its initial public offering of 9,722,223 Class A ordinary shares at a public offering price of $18.00 per share. In connection with the offering, vVARDIS has granted the underwriters a 30-day option to purchase up to an additional 1,458,333 Class A ordinary shares at the initial public offering price to cover over-allotments. The Class A ordinary shares are expected to begin trading on the New York Stock Exchange on November 13, 2026 under the symbol “VVVV.” The closing of the offering is expected to occur on or about November 16, 2026 subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint bookrunning managers for the offering, with William Blair, UBS Investment Bank and Deutsche Bank Securities acting as bookrunners. A registration statement on Form F-1 relating to the offering has been file
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom